Bio & Insurance Information

Dr. Ahn graduated the medical school from the Seoul National University College of Medicine and completed his residency and fellowship programs at the University of Arizona. He is specialized and board certified in Oncology. Dr. Ahn has been in practice for more than 20 years and is affiliated with the Corona Regional Medical Center. During his career, he has also contributed to 7 publications of medical interest.



Education & Training

Seoul National University College of Medicine

Medical School

University of Arizona

Residency

University of Arizona

Fellowship

Board Certifications

American Board of Internal Medicine - Oncology

Medical License

CA State Medical License: Active through 2013

American Board of Internal Medicine: Medical Oncology

Hospitals & Clinics

Corona Regional Medical Center

Languages: English/Spanish

(951) 737-4343

800 S Main St

Corona, California 92882

Read More

Orange Coast Memorial Medical Center

Languages: English/Spanish

(714) 378-7000

9920 Talbert Ave

Fountain Valley, California 92708

Read More

Parkview Community Hospital Medical Center

Languages: English/Spanish

(951) 688-2211

3865 Jackson St

Riverside, California 92503

Read More

Riverside Community Hospital

Languages: English/Spanish

(951) 788-3000

4445 Magnolia Ave

Riverside, California 92501

Read More

Publications

Dr. Sang Ahn has contributed to 3 publications.

Cell culture-adaptive mutations of NS5A affect replication of hepatitis C virus differentially depending on the viral genotypes.

Chung A, Jin B, Han K, Ahn SH, Kim S; J. Med. Virol.. 2017-01-01.

See more >>

Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adef...

Kim MN, Park JY, Ahn SH, Kim BK, Kim SU, Kim DY, Han K; J. Med. Virol.. 2017-01-01.

See more >>

Rapamycin-insensitive companion of mTOR (RICTOR) Amplification Defines a Subset of Advanced Gastric Cancer and is Sensitive to AZD2014-mediated mTORC1/2 Inhibition.

Kim ST, Kim SY, Klempner SJ, Yoon J, Kim N, Ahn S, Bang H, Kim K, Park W, Park SH, Park JO, Park YS, Lim HY, Lee SH, Park K, Kang WK, Lee J; Ann. Oncol.. 2016-12-27.

See more >>